IGIM
CYTK icon

I.G. Investment Management’s Cytokinetics CYTK Stock Holding History

I.G. Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-284,895
Closed -$1.36M – 863
2014
Q2 		$1.36M Buy
+284,895
New +$1.74M ﹤0.01% 555
2014
Q1 		– Sell
-216,300
Closed -$1.41M – 848
2013
Q4 		$1.41M Buy
216,300
+102,000
+89% +$670K 0.01% 505
2013
Q3 		$868K Buy
+114,300
New +$1.23M ﹤0.01% 603

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

I.G. Investment Management's CYTK Position: Q3 2014 in Review

I.G. Investment Management sold out of Cytokinetics (CYTK) in Q3 2014, closing a stake of 284,895 shares — an estimated $1.36M sold.

I.G. Investment Management first reported a position in CYTK in Q3 2013 and held it in 3 quarters. The position peaked at $1.41M in Q4 2013. 85 funds tracked by Wall St. Rank hold CYTK as of Q3 2014.

  • I.G. Investment Management reported no remaining Cytokinetics position as of Q3 2014 after selling out during the quarter.
  • I.G. Investment Management sold 284,895 Cytokinetics shares in Q3 2014, an estimated $1.36M.
  • I.G. Investment Management first reported a position in Cytokinetics in Q3 2013 and held it in 3 quarters.
  • I.G. Investment Management's Cytokinetics position peaked at $1.41M in Q4 2013.
  • 85 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2014.

Based on I.G. Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.